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Introduction. One of the major problems in cancer chemotherapy is the development of drug 
resistance during treatment. Currently, 90% of failures in chemotherapy are during the invasion 
and metastasis of cancers related to drug resistance that can develop in different mechanisms.  
Aim of the study. To study genetic mechanisms of drug resistance in cancer chemotherapy.  
Materials and methods.: This paper is a descriptive research, based on retrospective analysis. 
Analysis of statistical data, current management documents, reports, studies, bibliographic and 
digital sources have been carried out with reference to the topic.  
Results. The study of the genetic mechanisms of drug resistance in the treatment of cancer has 
identified the presence of different extracellular and intracellular mechanisms: tumor 
heterogeneity, tumor microenvironment, cancer stem cells, inhibition of cell death, inactivation 
of anticancer drugs, multi-drug resistance (MDR), changing drug metabolism, changing 
chemotherapeutic agents targets, enhancing DNA repair, gene amplification, epigenetic 
changes, microRNA. Responsible for multiplication, growth and metastasis have been shown 
to be some genes that encode for kinases. According to the latest studies, use of kinase inhibitor 
preparations is effective in both stopping progression of cancer and increasing the intracellular 
concentration of the preparation in MDR cells.  
Conclusions. Cancer drug resistance is a complex phenomenon determined by numerous 
mechanisms and some genes. Gaining knowledge about these particularities and performing 
genetic tests make it possible to avoid the misuse of the preparations, in order to prevent the 
chemotoxicity on the organism and affect the systems with a high division rate.  
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Introduction. Male infertility has multiple etiology, most commonly caused by 
spermatogenesis disorders, clinically manifested by oligo/azoospermia. Until recently, Y 
microdeletion had little clinical significance since men with a deletion were considered unable 
to reproduce. However, by utilizing of Intracytoplasmic sperm injection (ICSI) and Testicular 
sperm extraction (TESE) it is now possible for oligo/azoospermic men with Y microdeletion 
to father children.  
Aim of the study. To analyze the type of defect in spermatogenesis associated with specific Y 
deletions found in our IVF program, for prevention the transmission of these deletions through 
ICSI to offspring.  
